COLIRCUSI CICLOPLEJICO 1% price in UAE

Overview

Welcome to Dwaey, specifically on COLIRCUSI CICLOPLEJICO 1% Eye Drops page.
This medicine contains an important and useful components, as it consists of Cyclopentolate HCl.
COLIRCUSI CICLOPLEJICO 1% is available in the market in concentration 10mg/ml and in the form of Eye Drops.

CUSI LABORATORIES is the producer of COLIRCUSI CICLOPLEJICO 1% and it is imported from SPAIN, The most popular alternatives of COLIRCUSI CICLOPLEJICO 1% are listed downward .

Mode Of Action

Cyclopentolate is an anticholinergic. It produces dilatation of the pupil and paralysis of accommodation. Has a shorter duration of action than atropine.

Indication

Pediatric eye examinations
Mydriasis
Cycloplegia
Uveitis
Iritis

Precaution

This medicine is for use in the eyes only and must not be taken by mouth. These eye drops can cause blurred vision, difficulty focusing and sensitivity to light. The effects can last for up to 24 hours. You must not drive or take part in hazardous activities unless you can see clearly. You should not wear soft contact lenses during treatment with these eye drops. This is because they contain a preservative called benzalkonium chloride, which can be absorbed by soft contact lenses and cause eye irritation. Lactation: Excretion in milk unknown; use with caution

Side Effects

Blurred vision
Burning sensation in eye
Light intolerance
Tachycardia
Conjunctivitis
Raised intraocular pressure
Hyperreactive response in Down's syndrome children (atropine)
Drowsiness

Contra indication

Children under 3 months of age, Glaucoma, or people with a tendency to glaucoma because of a shallow anterior chamber, Conditions where the gut is not functioning properly, resulting in an obstruction in the bowel (paralytic ileus), Children with organic brain syndromes, including congenital or neuro-developmental abnormalities such as epilepsy. This medicine should not be used if history of allergies to one or any of its ingredients.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Plasma concentration may be increased with the use of cimetidine, diltiazem, disulfiram, methylphenidate, ritonavir, and verapamil. Side-effects are increased by adrenaline, amiodarone, general anesthetics, SSRIs, antihistamines, antimuscarinics, antipsychotics, anxiolytics and hypnotics, clozapine, disopyramide, diuretics, flecainide, MAOIs, moclobemide, moxifloxacin, nefopam, nicorandil, noradrenaline, phenothiazine, pimozide, procainamide, propafenone, quinidine, selegiline, sibutramine, sotalol, terfenadine, thioridazine, and tramadol. Effects of adrenergic neurone blockers, clonidine, barbiturates, nitrates, and primidone are reduced while effects of baclofen, opioid analgesics, and thyroid hormones are enhanced with concomitant use of cyclobenzaprine. Carbamazepine and rifampicin may increase metabolism of cyclobenzaprine. Effects may be antagonized by oestrogens. Avoid use with brimonidine, entacapone, artemether with lumefantrine, or sibutramine. CNS effects may be enhanced by other CNS depressants.